Business
New issue in connection with LTIP awards
New issue in connection with LTIP awards.
About this update from Oxford Nanopore Technologies Plc
[{"type":"text","content":"\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.\n \nFOR IMMEDIATE RELEASE\n \n10 OCTOBER 2024\n \nOxford Nanopore Technologies plc (\"Oxford Nanopore\" or \"the Company\")\n \nNew issue in connection with Oxford Nanopore's Long Term Incentive Plan\n \nOxford Nanopore announces that it intends to issue 12,500,789 ordinary shares of £0.0001 each (\"New Ordinary Shares\") to satisfy the release of awards under the Oxford Nanopore Technologies Limited Long-Term Incentive Plan 2021 (\"Founder LTIP\"), conditional only upon Admission (as defined below). The New Ordinary Shares will rank pari passu with existing ordinary shares in issue.\n \nApplications have been made to the Financial Conduct Authority and London Stock Exchange for the New Ordinary Shares to be admitted to the Equity shares (transition) category of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange (\"Admission\").\n \nAdmission is expected to occur at 8.00 a.m. on 14 October 2024.\n \nFor further information, please contact:\nOxford Nanopore Technologies plc\nInvestors: [email protected]\nMedia: [email protected]\n \nTeneo (communications adviser to the Company)\nTom Murray, Olivia Peters\n+44 (0) 20 7353 4200\[email protected]\nAbout Oxford Nanopore Technologies plc:\nOxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for real-time, high-performance, accessible and scalable analysis of DNA and RNA. The technology is used in more than 120 countries to understand the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses and whole environments. Oxford Nanopore Technologies products are intended for molecular biology applications and are not intended for diagnostic purposes.\nwww.nanoporetech.com\n \nForward-looking statements\nThis announcement contains certain forward...